Teva Pharmaceutical Industries Ltd ADR buy UBS Group AG
Start price
03.09.24
/
50%
€16.90
Target price
03.09.25
€23.55
Performance (%)
-6.51%
Price
07.10.24
€15.80
Summary
This prediction is currently active. With a performance of -6.51%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 03.09.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teva Pharmaceutical Industries Ltd ADR | -2.469% | -2.469% |
iShares Core DAX® | -1.958% | 4.037% |
iShares Nasdaq 100 | 0.272% | 8.670% |
iShares Nikkei 225® | 0.377% | 7.232% |
iShares S&P 500 | 0.370% | 6.511% |
Comments by UBS_Group_AG for this prediction
In the thread Teva Pharmaceutical Industries Ltd ADR diskutieren
Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target raised by analysts at UBS Group AG from $24.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for TEVA provided by MarketBeat
Stopped prediction by UBS_Group_AG for Teva Pharmaceutical Industries Ltd ADR
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€15.70
11.07.24
11.07.24
€22.04
11.07.25
11.07.25
0.64%
07.10.24
07.10.24
Teva Pharmaceutical Industries Ltd ADR
Start price
Target price
Perf. (%)
€8.94
27.11.23
27.11.23
€11.87
27.11.24
27.11.24
76.73%
07.10.24
07.10.24